| Dr Vance E Sherman, MD | |
|
1415 E Kincaid St, Psychiatry Dept, Mount Vernon, WA 98274-4126 | |
| (360) 424-2511 | |
| (360) 424-2522 |
| Full Name | Dr Vance E Sherman |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 33 Years |
| Location | 1415 E Kincaid St, Mount Vernon, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487883187 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Skagit Valley Hospital | Mount vernon, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Public Hospital Dist No 1 Skagit | 6800793522 | 248 |
News Archive
Walgreens had March sales of $6.43 billion, an increase of 4.5 percent from $6.16 billion for the same month in fiscal 2013.
Researchers at the University of Virginia examined the number and severity of subconcussive head impacts sustained by college football players over an entire season during practices and games. The researchers found that the number of head impacts varied depending on the intensity of the activity.
"Scientists have now provided revolutionary tools to roll back HIV but only a major funding boost, supported especially by emerging giant economies, will determine the outcome," according to experts speaking in Rome at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Agence France-Presse reports.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative medicines for eye disease, vascular disease and cancer, today announces results of a Phase IIa trial evaluating microplasmin intravitreal injection for the treatment of Diabetic Macular Edema (MIVI II DME).
› Verified 6 days ago
| Entity Name | Public Hospital Dist No 1 Skagit |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023332749 PECOS PAC ID: 6800793522 Enrollment ID: O20040309001059 |
News Archive
Walgreens had March sales of $6.43 billion, an increase of 4.5 percent from $6.16 billion for the same month in fiscal 2013.
Researchers at the University of Virginia examined the number and severity of subconcussive head impacts sustained by college football players over an entire season during practices and games. The researchers found that the number of head impacts varied depending on the intensity of the activity.
"Scientists have now provided revolutionary tools to roll back HIV but only a major funding boost, supported especially by emerging giant economies, will determine the outcome," according to experts speaking in Rome at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Agence France-Presse reports.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative medicines for eye disease, vascular disease and cancer, today announces results of a Phase IIa trial evaluating microplasmin intravitreal injection for the treatment of Diabetic Macular Edema (MIVI II DME).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vance E Sherman, MD 1400 E Kincaid St, Attn: Credentialing, Mount Vernon, WA 98274-4127 Ph: (360) 428-2500 | Dr Vance E Sherman, MD 1415 E Kincaid St, Psychiatry Dept, Mount Vernon, WA 98274-4126 Ph: (360) 424-2511 |
News Archive
Walgreens had March sales of $6.43 billion, an increase of 4.5 percent from $6.16 billion for the same month in fiscal 2013.
Researchers at the University of Virginia examined the number and severity of subconcussive head impacts sustained by college football players over an entire season during practices and games. The researchers found that the number of head impacts varied depending on the intensity of the activity.
"Scientists have now provided revolutionary tools to roll back HIV but only a major funding boost, supported especially by emerging giant economies, will determine the outcome," according to experts speaking in Rome at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Agence France-Presse reports.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative medicines for eye disease, vascular disease and cancer, today announces results of a Phase IIa trial evaluating microplasmin intravitreal injection for the treatment of Diabetic Macular Edema (MIVI II DME).
› Verified 6 days ago
Rozina Lakhani, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 1103 Cleveland Avenue, Mount Vernon, WA 98273 Phone: 360-336-6868 Fax: 360-336-6866 | |
Dr. Patti Jo Brettell, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1400 E Kincaid St, Mount Vernon, WA 98274 Phone: 336-042-8259 Fax: 360-428-2560 | |
Nathan Tolley, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1415 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-814-2422 Fax: 360-814-8215 | |
Mark H Backlund, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1103 Cleveland Ave, Mount Vernon, WA 98273 Phone: 360-336-6868 Fax: 360-336-6866 | |
Amir C Mazhari, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1400 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-428-2550 Fax: 360-428-6402 | |
Kathryn Anne Roberts, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1400 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-428-2550 Fax: 360-428-6402 |